東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ null ]

切換: 標籤 | MARC模式 | ISBD

Targeting Poly (ADP) Ribose Glycohyd...

Agostini, Lebaron C.,

FindBook

Google Book

Amazon

博客來

Targeting Poly (ADP) Ribose Glycohydrolase as a Combinatorial Strategy to Enhance DNA Damage in Gastrointestinal Cancers /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Targeting Poly (ADP) Ribose Glycohydrolase as a Combinatorial Strategy to Enhance DNA Damage in Gastrointestinal Cancers // Lebaron C Agostini.
作者:	Agostini, Lebaron C.,
面頁冊數:	1 electronic resource (129 pages)
附註:	Source: Dissertations Abstracts International, Volume: 82-09, Section: B.
Contained By:	Dissertations Abstracts International82-09B.
標題:	Cellular biology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28318299
ISBN:	9798582513834

Targeting Poly (ADP) Ribose Glycohydrolase as a Combinatorial Strategy to Enhance DNA Damage in Gastrointestinal Cancers /
Agostini, Lebaron C.,

Targeting Poly (ADP) Ribose Glycohydrolase as a Combinatorial Strategy to Enhance DNA Damage in Gastrointestinal Cancers /Lebaron C Agostini. - 1 electronic resource (129 pages)

Source: Dissertations Abstracts International, Volume: 82-09, Section: B.

The DNA damage response (DDR) pathway sets the stage for tumorigenesis and provides both an opportunity for drug efficacy and resistance. Therapeutic approaches to target the DDR pathway include; increasing cytotoxic chemotherapies' effectiveness and creating synergistic drug strategies to enhance DNA damage and cell death. Here, we report combinatorial targeting of Poly (ADP) Ribose Glycohydrolase (PARG) with other DDR proteins and cytotoxic agents as a novel therapeutic strategy to enhance DNA damage in gastrointestinal tumors, namely pancreatic ductal adenocarcinoma (PDAC) and Colorectal Carcinoma (CRC) tumors. Small molecule inhibition and genetic silencing of PARG were used to evaluate synthetic lethality and create a novel DDR targeted synergy in cancer cells. We demonstrated that homologous recombination deficiency (HRD) cancer cells were more sensitive to PARG inhibition and that potent drug synergy arises from combining PARG inhibition with DNA damaging agents.Additionally, we demonstrated that the Wee1 checkpoint kinase inhibitor adavosertib (AZD1775) was synergistic with PARG inhibition in (PDAC) and (CRC) cells in vitro and in vivo. Mechanistically, combined PARG inhibition and oxaliplatin treatment led to the persistence of detrimental PARylation, increased expression of cleaved caspase-3, and increased γH2AX foci. We also show mechanistically that PARG inhibition enhances DNA damage and replication stress when combined with Wee1 inhibition, resulting in increased cell death and S-phase specific DNA damage. These findings validate PARG as a relevant target in PDAC and CRC tumors and establish novel therapeutic strategies for combining DNA damaging agents with PARG inhibitors to increase apoptosis in gastrointestinal (GI) cancer cells.

English

ISBN: 9798582513834Subjects--Topical Terms:

3172791
Cellular biology.
Subjects--Index Terms:

Ribose

Targeting Poly (ADP) Ribose Glycohydrolase as a Combinatorial Strategy to Enhance DNA Damage in Gastrointestinal Cancers /
LDR:03276nmm a22004333i 4500 001 2434383
005 20251027113102.5
006 m o d
007 cr|nu||||||||
008 261011s2021 miu||||||m |||||||eng d
020 $a 9798582513834
035 $a (MiAaPQD)AAI28318299
035 $a AAI28318299
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Agostini, Lebaron C., $e author. $3 3824353
245 1 0 $a Targeting Poly (ADP) Ribose Glycohydrolase as a Combinatorial Strategy to Enhance DNA Damage in Gastrointestinal Cancers / $c Lebaron C Agostini.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 1 electronic resource (129 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 82-09, Section: B.
500 $a Advisors: Bordy, Jonathan Committee members: Languino, Lucia ; McMahon, Steven ; Benovic, Jeffery ; Astsaturov, Igor.
502 $b Ph.D. $c Thomas Jefferson University $d 2021.
520 $a The DNA damage response (DDR) pathway sets the stage for tumorigenesis and provides both an opportunity for drug efficacy and resistance. Therapeutic approaches to target the DDR pathway include; increasing cytotoxic chemotherapies' effectiveness and creating synergistic drug strategies to enhance DNA damage and cell death. Here, we report combinatorial targeting of Poly (ADP) Ribose Glycohydrolase (PARG) with other DDR proteins and cytotoxic agents as a novel therapeutic strategy to enhance DNA damage in gastrointestinal tumors, namely pancreatic ductal adenocarcinoma (PDAC) and Colorectal Carcinoma (CRC) tumors. Small molecule inhibition and genetic silencing of PARG were used to evaluate synthetic lethality and create a novel DDR targeted synergy in cancer cells. We demonstrated that homologous recombination deficiency (HRD) cancer cells were more sensitive to PARG inhibition and that potent drug synergy arises from combining PARG inhibition with DNA damaging agents.Additionally, we demonstrated that the Wee1 checkpoint kinase inhibitor adavosertib (AZD1775) was synergistic with PARG inhibition in (PDAC) and (CRC) cells in vitro and in vivo. Mechanistically, combined PARG inhibition and oxaliplatin treatment led to the persistence of detrimental PARylation, increased expression of cleaved caspase-3, and increased γH2AX foci. We also show mechanistically that PARG inhibition enhances DNA damage and replication stress when combined with Wee1 inhibition, resulting in increased cell death and S-phase specific DNA damage. These findings validate PARG as a relevant target in PDAC and CRC tumors and establish novel therapeutic strategies for combining DNA damaging agents with PARG inhibitors to increase apoptosis in gastrointestinal (GI) cancer cells.
546 $a English
590 $a School code: 0272
650 4 $a Cellular biology. $3 3172791
650 4 $a Oncology. $3 751006
650 4 $a Molecular biology. $3 517296
650 4 $a Biochemistry. $3 518028
653 $a Ribose
653 $a Glycohydrolase
653 $a DNA damage
653 $a Gastrointestinal cancer
690 $a 0379
690 $a 0992
690 $a 0487
690 $a 0307
710 2 $a Thomas Jefferson University. $b Genetics. $e degree granting institution. $3 3824354
720 1 $a Bordy, Jonathan $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 82-09B.
790 $a 0272
791 $a Ph.D.
792 $a 2021
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28318299